The present invention relates to new uses of Solute Carrier 6 (SC6), a
taurine transporter, in the diagnosis, screening, treatment and
prophylaxis of hypoxia related conditions e.g. cancer. Compositions
comprising the protein, such as vaccines and agents that modulate the
protein expression or activity, including antibodies that are
immunospecific for the protein, are also provided.